Top Medical News from Across Medscape

  • Most Physicians Think FDA Has It About Right, Survey SaysMost physician respondents thought the FDA requires the right level of evidence for approving new drugs but were overwhelmingly against the FDA allowing promotion of drugs for unapproved uses.
  • New Paper: How to Get Patients With Diabetes/CVD Moving'Just advising patients to exercise...is not enough,' says the lead author of a European society position paper. 'Patients must be assessed for comorbidities, risks...and personal preferences.'
  • Intermittent Fasting Plus Lower-Calorie Diet May Be BestAlthough admittedly small, a new study indicates that a combination of intermittent fasting together with some calorie restriction may give the best outcomes in terms of weight loss and overall health.
  • CMS Seeks to Prod Insurers to Negotiate Lower Drug PricesCMS' Seema Verma proposed a voluntary test to address what she calls "perverse incentives" in Part D. The model will ask insurers to accept more financial risk for customers who need expensive drugs.

Special Report

Business of Medicine

  • New Malpractice Risks in Your EHR Working with an EHR can be difficult, but even worse, there are ways that your data input could work against you if a possible malpractice lawsuit arises.
  • Do Politics Have a Place in the Exam Room? As demonstrated in the 2018 Medscape Ethics Report, opinions vary on whether discussing politics with patients is fine or jeopardizes relationships.

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California